|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 68.27 USD | +2.12% |
|
+8.78% | -1.71% |
| 07-31 | UBS Adjusts Exponent Price Target to $72 From $75, Maintains Neutral Rating | MT |
| 07-31 | Exponent, Inc., Q2 2026 Earnings Call, Jul 30, 2026 |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 84 | +25.65% | 3 | ||||||
| 215.38 | +5.25% | 16 | ||||||
| 127.91 | +16.56% | 11 | ||||||
| 156.53 | +16.01% | 15 | ||||||
| 32.23 | +16.53% | 17 | ||||||
| 59.14 | +1.27% | 12 | ||||||
| 24.52 | +13.48% | 13 | ||||||
| 303.33 | +5.54% | 12 | ||||||
| 39.27 | +11.67% | 11 | ||||||
| 74.38 | +11.01% | 8 | ||||||
| - | 273.33 | -6.71% | 3 | |||||
| 44.38 | +30.78% | 8 | ||||||
| 152 | +28.32% | 2 | ||||||
| 74 | +7.25% | 14 | ||||||
| 1,358 | +15.77% | 5 | ||||||
| 2.041 | -1.42% | 8 | ||||||
| - | 50.27 | +6.88% | 3 | |||||
| - | 105 | +74.27% | 2 | |||||
| 3.106 | +28.55% | 12 | ||||||
| Average | 167.31 | +16.14% | 9 | ||||||
| Weighted average by Cap. | 167.47 | +11.03% | 13 |
- Stock Market
- Stocks
- EXPO Stock
- Sector Exponent, Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
